3 news items
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
AEMD
AMC
ARQT
15 May 24
Stifel analyst Stephen Willey downgraded the stock from Buy to Hold and lowered the price target from $6 to $1.5.
Bolt Biotherapeutics shares
BMO Capital Maintains Market Perform on Telos, Lowers Price Target to $4
TLS
13 May 24
BMO Capital analyst Keith Bachman maintains Telos (NASDAQ:TLS) with a Market Perform and lowers the price target from $4.5 to $4.
Wedbush Reiterates Outperform on Telos, Maintains $6 Price Target
TLS
13 May 24
Wedbush analyst Daniel Ives reiterates Telos (NASDAQ:TLS) with a Outperform and maintains $6 price target.
- Prev
- 1
- Next